1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > The U.S. Market for Biodefense-Related Rapid Pathogen Identification and Treatments

The U.S. Market for Biodefense-Related Rapid Pathogen Identification and Treatments

  • August 2015
  • -
  • BCC Research
  • -
  • 144 pages

Summary

Table of Contents

Use this report to:
- Identify current trends and emerging technologies pertinent to biological rapid pathogen identification.
- Analyze treatment methods such as vaccines and pharmaceuticals in the U.S. biodefense-related rapid pathogen market.
- Learn about manufacturers of assays, sensors, vaccines and pharmaceuticals used in the identification and treatment of biological agents.Use this report to:
- Identify current trends and emerging technologies pertinent to biological rapid pathogen identification.
- Analyze treatment methods such as vaccines and pharmaceuticals in the U.S. biodefense-related rapid pathogen market.
- Learn about manufacturers of assays, sensors, vaccines and pharmaceuticals used in the identification and treatment of biological agents.

Highlights
- The U.S. market for biodefense-related rapid pathogen detection devices was valued at $214.2 million in 2015. The total market is projected to grow at a compound annual growth rate (CAGR) of 8% from 2016 through 2021 to reach $248 million by 2016 and $364 million by 2021.
- Detection devices are projected to grow at a CAGR of 5.2% from $155 million by 2016 to $200 million by 2021.
- The sensors devices market is projected to reach $93 million by 2016. It is projected to increase at a CAGR of 12% and reach $164 million by 2021.

Introduction & Scope

INTRODUCTION

REASONS FOR DOING THE STUDY
The U.S. found itself in the unusual position of being attacked by a foreign entity in 2001, and preparations for such an attack were woefully inadequate. Since then, the U.S. government has given priority to preparations for potential biological attacks by incentivizing industry and academia to develop pathogen identification and treatment products. Pathogenic agents can be viruses, bacteria, fungi, protozoa, parasites, or manufactured toxins. They are able to cause diseases in plants, animals and humans. Pathogens that are harmful to animals and plants are not covered unless they pose eminent danger to humans through consumption. Examples of infectious agents discussed include smallpox, anthrax, plague and tularemia. Another area of pathogen identification includes potentially harmful chemical toxins that are used in biological warfare situations. These include ricin and botulin.

The market for biodefense-related rapid pathogen identification products continues to expand with an emphasis on products that are more portable, easy to use, sensitive and accurate. Multiple assays are being field-tested and used by military personnel, first responders, industry and businesses. The purpose for this report is to provide an overview of the industry and its participants, and project the growth of the market through 2021.

STUDY GOALS AND OBJECTIVES
Biological substances that can be weaponized for either civilian or military destruction are considered biodefense related, and identifying these substances accurately and rapidly is at the heart of this report. Additionally, treatment methods such as vaccines and pharmaceuticals will be discussed. The report concentrates on the U.S. biodefense-related rapid pathogen identification and treatment markets.

This report is intended to:
- Provide an accurate overview of the biological warfare landscape and the infectious agents that could pose the most acute problems.
- Discuss the pathogen identification products currently on the market and their potential for growth.
- Identify current trends and emerging technologies pertinent to biological rapid pathogen identification.
- Provide an overview of recently issued patents related to biological rapid pathogen identification.
- Include a comprehensive directory of manufacturers of assays, sensors, vaccines and pharmaceuticals used

INTENDED AUDIENCE
This new report on the biodefense-related rapid pathogen identification and treatment market will be a valuable tool for decision makers and manufacturers in biodefense rapid pathogen diagnostic, vaccine and the pharmaceutical treatment industries. Individuals at research foundations, manufacturing companies and university laboratories will find valuable information on the U.S. biodefense market, and individuals involved in strategic planning, marketing and sales development will appreciate the specificity of the report. Additionally, emphasis on the type of disease, major players in the marketplace, market conditions, and current and projected revenues will be provided.

SCOPE AND FORMAT
The market report organizes information from diverse sources into a cohesive unit that includes an industry overview; overview of infectious agents with detection, vaccine and treatment information; biodefense-related diagnostic tools; current research and emerging industries related to rapid pathogen identification; biodefense-related pathogen identification product patents; and a comprehensive directory of assay,
sensor, vaccine and treatment companies.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

  • $ 59500
  • Industry report
  • January 2017
  • by Venture Planning Group

This unique 68-country survey from VPGMarketResearch.com provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well ...

2017 World Transfusion Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Middle East--Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

2017 World Transfusion Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Middle East--Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

  • $ 43500
  • Industry report
  • January 2017
  • by Venture Planning Group

This comprehensive 68-country report from VPGMarketResearch.com provides granular data and analysis not available from any other source. The report is designed to help current suppliers and potential market ...

2017 World Blood Typing, Grouping and Infectious Disease Screening Market: North America, Europe, Asia-Pacific, LATAM, Middle East--Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

2017 World Blood Typing, Grouping and Infectious Disease Screening Market: North America, Europe, Asia-Pacific, LATAM, Middle East--Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

  • $ 43500
  • Industry report
  • January 2017
  • by Venture Planning Group

This comprehensive 68-country report from VPGMarketResearch.com provides granular data and analysis not available from any other source. The report is designed to help current suppliers and potential market ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.